Cancer Gene Therapy Market was valued at US$ 2.13 Bn in 2022 and is expected to reach US$ 9.31 Bn by 2029, at a CAGR of 23.42% during a forecast period. Cancer gene therapy is a method of treating cancer disease by changing the genetic instructions within an individual’s cells. It is used as a substitute for drugs and surgeries to treat cancer because of the high success rate achieved by trials.Cancer Gene Therapy Market Dynamics:
Cancer disease occurs because of disrupting the normal cell proliferation and apoptosis process. The advancement in cancer therapy requiresa novel therapeutic agent with a mode of action, mechanisms of cell death and interaction with conventional management. The gene therapy approacheswere developed for the management of cancer, which includesanti-angiogenic gene therapy, pro-apoptotic gene therapy and gene directed-enzyme prodrug therapy.To Know About The Research Methodology :- Request Free Sample Report High prevalence of cancer, government initiatives, continuous research & development in the production of cancer gene therapy products, and collaborations to develop gene-therapy products are some of the prominent driving factors behind the global cancer gene therapy market growth. By 2021, greater than 3000 clinical trials were conducted across the globe. Among these trials, greater than 70% are associated with cancer. According to the updated Globocan 2021 estimation, the global cancer burden is indicating that it has risen to 19.3 million cases and more than 10 million cancer deaths in 2021. On the other hand, thehigh cost of gene therapy treatment, annoying immune responses, and risk allied with the treatment are expected to limit the global cancer gene therapy market growth during the forecast period. The Liability of Cancer Worldwide: Cancer is one of the leading causes of death worldwide. In 2022, there were xx.1 million new cases and xx million cancer-related deaths worldwide. By 2029, the number of new cancer cases is expected to grow to more than 20 million. The hospital segment is expected to grow at an xx% rate of CAGR during the forecast period. The demand for cancer disease treatment is increasing at an exponential rate. The hospital segment is responding to life-threatening emergencies and many routine health problems that nevertheless require prompt action. High demand for multi-speciality treatment and devices and consumer preference towards innovative surgical procedures performed in hospitals is expected to drive the market growth during the forecast period. North America is supposed to lead the global cancer gene therapy market. North America has dominated the global cancer gene therapy market in 2022. The trend is projected to continue its dominance in the near future because of the growth in the geriatric populations, the presence of well-established healthcare infrastructure for the treatment of cancer and technological developments in the gemmotherapy segment. Also, improvedregulatory standards regarding the quality of products, which are used in gene therapy, high investment in R&D activities, adoption of DNA vaccines and acceptance of the gene therapy treatments are some of the driving factors of the regional market growth. Cancer death in 2021 in the United States: In 2021, 1,806,590 new cases of cancer have diagnosed in the United States In 2021, there were more than 16.9 million cancer survivors in the United States. The number of cancer survivors is expected to increase to 19.2 million by 2029. Asia Pacific is also expected to grow at an xx% rate of CAGR during the forecast period. The presence of the geriatric population is one of the key drivers in the global market. An increase inthe prevalence of cancer, innovation and development in cancer gene therapy are expected to enhance the market regional market growth by 2029. A number of new cancer cases in 2021 In India: The objective of the report is to present a comprehensive analysis of the Global Cancer Gene Therapy Marketincluding all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the Global Cancer Gene Therapy Market dynamics, structure by analyzing the market segments and projects the Global Cancer Gene Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Cancer Gene Therapy Market make the report investor’s guide.
Global Cancer Gene Therapy Market Scope: Inquire before buying
Global Cancer Gene Therapy Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.13 Bn. Forecast Period 2023 to 2029 CAGR: 23.42% Market Size in 2029: US $ 9.31 Bn. Segments Covered: by Therapy Type Gene Induced Immunotherapy Delivery of Cytokines Gene Delivery of Tumor Antigen Gene OncolyticVirotherapy Adenovirus Lentivirus Retro Virus Adeno Associated Virus Herpes Simplex Virus Alpha Virus Vaccinia Virus Simian Virus Others Gene Transfer Naked/Plasmid Vectors Electroporation Sonoportion Magnetofection Gene Gun by End User Hospitals Diagnostics Centers Research Institutes Global Cancer Gene Therapy Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Global Cancer Gene Therapy Market Key Players
1.Shenzhen SibionoGenetech 2.Glaxosmithkline 3.Oncogenex Pharmaceuticals 4.Bluebird Bio, Inc. 5.Synergene Therapeutics 6.Shanghai Sunway Biotech 7.Biocancell 8.Celgene 9.Merck 10.ZioPharm Oncology 11.MolMed 12.bluebird bio 13.MultiVir 14.Adaptimmune Therapeutics plc 15.Amgen Inc 16.Anchiano Therapeutics 17.Achieve Life Sciences, Inc 18.Advantagene 19.GenVec 20.Cell Genesys 21.Introgen Therapeutics 22.Altor Bioscience Frequently Asked Questions: 1. Which region has the largest share in Global Cancer Gene Therapy Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Cancer Gene Therapy Market? Ans: The Global market is growing at a CAGR of 23.42% during forecasting period 2023-2029. 3. What is scope of the Global Cancer Gene Therapy market report? Ans: Global Cancer Gene Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cancer Gene Therapy market? Ans: The important key players in the Global Cancer Gene Therapy Market are – Shenzhen SibionoGenetech, Glaxosmithkline, Oncogenex Pharmaceuticals, Bluebird Bio, Inc., Synergene Therapeutics, Shanghai Sunway Biotech, Biocancell, Celgene, Merck, ZioPharm Oncology, MolMed, bluebird bio, MultiVir, Adaptimmune Therapeutics plc, Amgen Inc, Anchiano Therapeutics, Achieve Life Sciences, Inc, Advantagene, GenVec, Cell Genesys, Introgen Therapeutics, and Altor Bioscience 5. What is the study period of this market? Ans: The Global Cancer Gene Therapy Market is studied from 2022 to 2029.
Global Cancer Gene Therapy Market
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cancer Gene Therapy Market Size, by Market Value(US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cancer Gene Therapy Market 3.4. Geographical Snapshot of the Cancer Gene Therapy Market, By Manufacturer share 4. Global Cancer Gene Therapy Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Sizes 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Cancer Gene Therapy Market 5. Supply Side and Demand Side Indicators 6. Global Cancer Gene Therapy Market Analysis and Forecast, 2022-2029 6.1. Global Cancer Gene Therapy Market Size & Y-o-Y Growth Analysis. 7. Global Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 7.1.1. Gene Induced Immunotherapy 7.1.1.1. Delivery of Cytokines Gene 7.1.1.2. Delivery of Tumor Antigen Gene 7.1.2. OncolyticVirotherapy 7.1.2.1. Adenovirus 7.1.2.2. Lentivirus 7.1.2.3. Retro Virus 7.1.2.4. Adeno Associated Virus 7.1.2.5. Herpes Simplex Virus 7.1.2.6. Alpha Virus 7.1.2.7. Vaccinia Virus 7.1.2.8. Simian Virus 7.1.2.9. Others 7.1.3. Gene Transfer 7.1.3.1. Naked/Plasmid Vectors 7.1.3.2. Electroporation 7.1.3.3. Sonoportion 7.1.3.4. Magnetofection 7.1.3.5. Gene Gun 7.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 7.2.1. Hospitals 7.2.2. Diagnostics Centers 7.2.3. Research Institutes 8. Global Cancer Gene Therapy Market Analysis and Forecasts, By Region 8.1. Market Size (Mn) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 9.1.1. Gene Induced Immunotherapy 9.1.1.1. Delivery of Cytokines Gene 9.1.1.2. Delivery of Tumor Antigen Gene 9.1.2. OncolyticVirotherapy 9.1.2.1. Adenovirus 9.1.2.2. Lentivirus 9.1.2.3. Retro Virus 9.1.2.4. Adeno Associated Virus 9.1.2.5. Herpes Simplex Virus 9.1.2.6. Alpha Virus 9.1.2.7. Vaccinia Virus 9.1.2.8. Simian Virus 9.1.2.9. Others 9.1.3. Gene Transfer 9.1.3.1. Naked/Plasmid Vectors 9.1.3.2. Electroporation 9.1.3.3. Sonoportion 9.1.3.4. Magnetofection 9.1.3.5. Gene Gun 9.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 9.2.1. Hospitals 9.2.2. Diagnostics Centers 9.2.3. Research Institutes 10. North America Cancer Gene Therapy Market Analysis and Forecasts, By Country 10.1. Market Size (Mn) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 11.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 12. Canada Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 12.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 13. Mexico Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 13.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 14. Europe Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 14.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 15. Europe Cancer Gene Therapy Market Analysis and Forecasts, By Country 15.1. Market Size (Mn) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 16.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 17. France Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 17.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 18. Germany Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 18.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 19. Italy Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 19.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 20. Spain Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 20.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 21. Sweden Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 21.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 22. CIS CountriesCancer Gene Therapy Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 22.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 23. Rest of Europe Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 23.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 24. Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 24.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 25. Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, by Country 25.1. Market Size (Mn) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 26.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 27. India Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 27.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 28. Japan Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 28.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 29. South Korea Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 29.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 30. Australia Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 30.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 31. ASEAN Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 31.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 32. Rest of Asia Pacific Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 32.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 33. Middle East Africa Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 33.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 34. Middle East Africa Cancer Gene Therapy Market Analysis and Forecasts, by Country 34.1. Market Size (Mn) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 35.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 36. GCC Countries Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 36.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 37. Egypt Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 37.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 38. Nigeria Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 38.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 39. Rest of ME&A Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 39.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 40. South AmericaCancer Gene Therapy Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 40.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 41. South America Cancer Gene Therapy Market Analysis and Forecasts, by Country 41.1. Market Size (Mn) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 42.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 43. Argentina Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 43.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 44. Rest of South America Cancer Gene Therapy Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Mn) Estimates & Forecast By Material Type, 2022-2029 44.2. Market Size (Mn) Estimates & Forecast By End User, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cancer Gene Therapy Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, End Users and R&D investment 45.2.2. New Size Launches and Size Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and End Users 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile - Key Players 45.3.1. Shenzhen SibionoGenetech 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Size Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Glaxosmithkline 45.3.3. Oncogenex Pharmaceuticals 45.3.4. Bluebird Bio, Inc. 45.3.5. Synergene Therapeutics 45.3.6. Shanghai Sunway Biotech 45.3.7. Biocancell 45.3.8. Celgene 45.3.9. Merck 45.3.10. ZioPharm Oncology 45.3.11. MolMed 45.3.12. bluebird bio 45.3.13. MultiVir 45.3.14. Adaptimmune Therapeutics plc 45.3.15. Amgen Inc 45.3.16. Anchiano Therapeutics 45.3.17. Achieve Life Sciences, Inc 45.3.18. Advantagene 45.3.19. GenVec 45.3.20. Cell Genesys 45.3.21. Introgen Therapeutics 45.3.22. Altor Bioscience